Collaborators
Therapeutic Frontiers Ltd, COLDPREV II Enzymatica, 2016 - 2017
MedImmune Inc., MedImmune Inc., Characterisation of a human ICAM-1 transgenic mouse model for determination of the efficacy ofanti-ICAM-1 directed mAbs in major group HRV infection and HRV induced asthma exacerbation., 2010 - 2011
AstraZeneca UK, AstraZeneca UK, Anti-ICAM approaches in RV infections., 2009 - 2010
GlaxoSmithKline UK, GlaxoSmithKline UK, Investigating the effects of combined steroid and β2 agonist on innate anti-infective immune responses in epithelial cells and macrophages., 2009 - 2011
AstraZeneca UK, AstraZeneca UK, Characterising the molecular defect in interferon production in asthma., 2007 - 2010
AstraZeneca UK, AstraZeneca UK, The effect of CCR3 antagonism on RSV transmissibility, 2006 - 2007
Pfizer, Pfizer, Development of an experimental model of rhinovirus induced COPD exacerbations., 2005 - 2007
Merck Sharp & Dohme Ltd, Merck Sharp & Dohme Ltd, The role of leukotrienes in acute exacerbations of COPD., 2005 - 2007
Sanofi-Pasteur, Sanofi-Pasteur, Use of adjuvants to manipulate immune responses to rhinovirus infections., 2005 - 2012
Centocor, USA, Centocor, USA, Discovery of novel therapies for asthma exacerbations., 2005 - 2011
Millennium Inc, Millennium Inc, Role of epithelial cell costimulatory molecule expression in rhinovirus infection., 2004 - 2005
GlaxoSmithKline, GlaxoSmithKline, Epidemiology of the respiratory viral infections in children aged 12-47 months., 2004 - 2005
National Jewish Medical study & Research Center,Denver,Colorado, National Jewish Medical study & Research Center,Denver,Colorado, The COPSAC virus study, 2004 - 2006
Merck Inc, Merck Inc, Previa study, 2003 - 2004
GlaxoSmithKline, GlaxoSmithKline, Development of an experimental model of rhinovirus induced COPD exacerbation., 2001 - 2007
SmithKline Beecham USA, SmithKline Beecham USA, The role of p38 kinase in NF-kB activation by rhinovirus., 2000 - 2001
SmithKline Beecham USA, SmithKline Beecham USA, The role of virus infections in exacerbations of COPD., 2000 - 2002
GlaxoSmithKline, GlaxoSmithKline, Molecular mechanisms of inhibition by fluticasone, salmeterol and the combination of rhinovirus induction of pro-inflammatory molecules., 2000 - 2008
GlaxoWellcome UK, GlaxoWellcome UK, Development of a transgenic mouse model rhinovirus infection and asthma exacerbation., 1999 - 2004
GlaxoWellcome UK, GlaxoWellcome UK, Taqman quantification of virus load in asthma exacerbations., 1998 - 1999
Schering-Plough USA, Schering-Plough USA, A double-blind, placebo controlled study on the effect of Claritin on virus induced wheeze in school children., 1997 - 1999
Lederle-Wyeth, Lederle-Wyeth, Role of viral infections in acute wheezing episodes leading to hospital admission in adults., 1997 - 1998
Schering-Plough USA, Schering-Plough USA, Loratidine and mometasone inhibition of rhinovirus induction of ICAM-1., 1997 - 1999
Abbott Pharmaceuticals, Abbott Pharmaceuticals, Prevalence of chronic Chlamydia pneumoniae infection in normal and asthmatic adults., 1996 - 1998
Hoechst, Hoechst Marrion Roussell, Induction of pro-inflammatory mediators by chronic Chlamydia pneumoniae infection in epithelial cells pneumoniae infection in epithelial cells, 1996 - 1998
Zeneca UK, Zeneca UK, A double blind study on the effect of Accolate of virus-induced asthma exacerbations in adult asthmatic subjects., 1996 - 1998
Prof M Sears, Hamilton Canada
Don Milton, Harvard University
Prof P Holt, Perth Australia
Guest Lectures
At least 20 invited lectures at International Congresses per year
Research Student Supervision
Almond,M, PhD
Beale,J, PhD
Chanarin,N, PhD
Chauhan,AJ, PhD
Ching,YM, PhD
Coneely,A, PhD
Corne,J, PhD
Dhariwal,J, PhD
Farne,H, PhD
George,P, PhD
Gielen,V, PhD
Glanville,N, PhD
Guedan,A, PhD
Haas,J, PhD student
Hewson,C, PhD
Hussain,IR, PhD
Jackson,D, PhD
Jayaraman,A, PhD
Legg,J, PhD
Mallia,P, PhD
Message,S, PhD
Oliver,B, PhD
Parker,H, PhD
Peel,T, PhD
Porter,J, PhD
Slater,L, PhD
Sykes,A, PhD
Walton,R, PhD
Wong,E, PhD